Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Polybiocept Aktiebolag
AB
Bankrupt
Org 5568492291
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 15 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Polybiocept Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
27M
21M
14M
7M
0M
2015: 0M
0M
2015
2016: 22M
22M
2016
2017: 2M (-91% vs 2016)
2M
-91%
2017
2018: 0M (-100% vs 2017)
0M
-100%
2018
EBITDA
SEK millions
17M
13M
9M
4M
0M
2015: 0M
0M
2015
2016: 14M
14M
2016
2017: 1M (-93% vs 2016)
1M
-93%
2017
2018: 0M (-100% vs 2017)
0M
-100%
2018
Income statement
SEK thousands
Item
2018
2017
2016
2015
Revenue
0
1 876
22 038
0
Staff expenses
—
—
—
—
EBITDA
286
875
14 270
−280
Depreciation & amort.
−0
−249
−481
−0
EBIT
286
626
13 789
−280
Net financials
−145
−48
—
−2
Profit before tax
142
577
13 789
−282
Tax
−53
−41
−2 980
−0
Net profit
89
536
10 809
−282
Balance sheet
SEK thousands
Item
2018
2017
2016
2015
Total assets
6 090
10 270
19 056
880
Equity
2 496
900
11 562
752
Long-term debt
1 977
2 004
0
0
Short-term debt
1 617
7 367
7 495
127
Total debt
3 594
9 371
7 495
127
Financial ratios
5-year trend
EBITDA margin
>999 %
This company
15,8 %
Market median
This company
Market median
>999% above market
2015
2018
Equity ratio
41,0 %
This company
38,2 %
Market median
This company
Market median
7% above market
2015
2018
Return on equity
3,6 %
This company
18,4 %
Market median
This company
Market median
80% below market
2015
2018
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2015
2018
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2015
2018
Debt / equity
1,44×
This company
0,62×
Market median
This company
Market median
132% above market
2015
2018
Annual reports & filings
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
View
PDF
Annual report 2015
Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
View
PDF
More on Polybiocept Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
